Interestingly, we also show that PDL1/2 promoter hypomethylation and expression are strongly associated with a glycolytic-high phenotype, layering a potential epigenetic immunosuppressive explanation for the poorer prognosis of IDH-wt glioma patients. Here, CD274 is linked to central nervous system cancer.